Sign in
HURA Stock Price, Chart, Stats & News
TuHURA Biosciences, Inc.
Save
TuHURA Biosciences, Inc. (HURA) does not currently pay a dividend.
112.16M
Market cap
–
Current P/E
–
Forward P/E
HURA chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -113.97% |
ROE | -193.06% |
D/E | 0.03x |
Interest coverage ratio | -54.36x |
HURA valuation
P/E | – |
P/S | – |
P/B | 5.47x |
P/CF | -3.12x |
P/FCF | -3.46x |
P/OCF | -3.12x |
PEG | -0.04x |
EV multiple | -3.64x |
About
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Similar securities
Based on sector and market capitalization
Report issue